Nektar Therapeutics

NASDAQ: NKTR · Real-Time Price · USD
0.61
0.00 (0.73%)
At close: May 08, 2025, 2:53 PM

Nektar Therapeutics Revenue

Nektar Therapeutics reported an annual revenue of $98.43M, reflecting a 9.22% growth. For the quarter ending December 31, 2024, Nektar Therapeutics generated $29.18M in revenue.
Revenue (ttm)
$98.43M
Revenue Growth
9.22%
Price / Sales Ratio
1.94
Revenue / Employee
$1.61M
Employees
61
Market Cap
112.83M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.